News

Published on 14 Apr 2024 on Motley Fool via Yahoo Finance

Is AbbVie a Millionaire Maker?


Article preview image

Big pharma stocks like AbbVie (NYSE: ABBV) usually aren't high on the list that investors look to for opportunities that could make them into millionaires. After all, they aren't typically in the news for good reasons, and despite relying on the lifesaving medicines that they produce, most people aren't talking to their coworkers about how their products are going to be in every household or core enablers for some grand global trend.

But as keen investors know, sometimes the best opportunities are lying ignored in plain sight. So let's take a minute to evaluate whether a timely investment in AbbVie could make you millions and under what conditions.

NYSE.ABT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
2 Beaten-Down Dividend Stocks to Buy and Hold Forever

Finding "forever" stocks isn't easy. Corporations that can thrive and pay dividends for long peri...

Motley Fool via Yahoo Finance 28 Apr 2024

Better Dividend Stock: AbbVie or Johnson & Johnson?

There are many dividend stocks on the market, but few are as prominent as AbbVie (NYSE: ABBV) and...

Motley Fool via Yahoo Finance 28 Apr 2024

3 Dividend Stocks to Buy and Hold for the Next Decade

Buy, hold, rake in solid income. That sounds like a pretty good investing strategy. You only have...

Motley Fool via Yahoo Finance 27 Apr 2024

This Steel Maker’s Buyback Backfired. How Not to Get Burned.

Problems at Cleveland-Cliffs and 3M highlight the dangers when chasing high dividend yields. One ...

Barrons.com 25 Apr 2024

What's in Store for These 4 Medical Products Stocks in Q1 Earnings?

Several large-cap MedTech players have already announced first-quarter results. Among them, Abbot...

Zacks via Yahoo Finance 23 Apr 2024

Ford shares surge on Tesla's EV price cuts as the legacy automaker falls back on its roots

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just i...

CNBC 22 Apr 2024

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a go...

Zacks via Yahoo Finance 22 Apr 2024

Barclays cuts Abbott Labs stock target, maintains Overweight By Investing.com

Despite the slight decrease in the target, the firm continues to recommend an Overweight rating o...

Investing.com 22 Apr 2024

We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation

Key Insights Abbott Laboratories to hold its Annual General Meeting on 26th of AprilTotal pay for...

Simply Wall St. via Yahoo Finance 20 Apr 2024

Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript

Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript April 17, 2024 Abbott Laboratorie...

Insider Monkey via Yahoo Finance 18 Apr 2024